Breaking News
A study has found measurements of C-reactive protein (CRP), lactate dehydrogenase (LDH) and albumin are potentially predictive markers for disease severity in children hospitalized with COVID-19.
The U.S. Food and Drug Administration (FDA) has approved and granted emergency use authorization for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2.
A study by researchers at Washington University School of Medicine in St. Louis indicates next-generation vaccines that target a virus’s points of entry — the nose and mouth — may be able to contain the spread of respiratory infections and prevent transmission.
BioTrending
- By Ronale Tucker Rhodes, MS
Known as the silent killer, hypertension often goes undetected in individuals until a serious event occurs. However, with a better understanding of the condition and regular monitoring, it can be managed with treatment.
- By Jim Trageser
While neutropenia can be a life-threatening condition, physicians have many tools to treat it.
- By Amy Scanlin, MS
Through regulatory pathways and patient engagement, FDA is helping to advance treatment innovations for rare diseases.
- By Trudie Mitschang
Despite scientific evidence to the contrary, doubts about vaccine safety and efficacy have not only persisted, but escalated. Counteracting this wave of mistrust will require targeted tactics and networked, community involvement.
BSTQ Podcast: Marketplace News & Insights
Understanding the Insurance Reimbursement Process in Specialty Pharmacy
Special guest expert Leslie Vaughan, Chief Operating Officer of Nufactor, discusses the insurance reimbursement process in specialty pharmacy and how to make it easier for patients.
Awards
BSTQ is an Industry Award-Winning Journal
Since its debut in 2009, BioSupply Trends Quarterly’s articles have been recognized by some of the industry’s most prominent organizations, earning platinum and gold awards.
